BRAND_ANALYSIS#JOHNSON_AND_JOHNSONHEALTH & PHARMA#1 OF 26 IN HEALTH & PHARMAHIGH TENSION
Johnson & Johnson
· Public · Updated 22 Nov 2026 07:19 UTC
#7 of 1208 overall by tension · #1 of 26 in Health & Pharma
40High Tension
The Silent Giant
Analysis
J&J at T=40 is the definition of institutional inertia — high business score, flat culture, 1.07% stock movement that barely registers as news. The brand has spent years legally and structurally separating itself from its own controversies, and the data reflects the result: a company that is neither loved nor hated with any intensity. Competent, cold, durable.
IN THE NEWS (49 articles this week)
Johnson & Johnson to Buy Ollin Biosciences for $2.2 Billion - WSJ
Needing More Trey McBride, Hello Josh Johnson, And Friday Before The Chiefs - Arizona Cardinals
Highs Member Sentenced to 460 Months in Prison for RICO Conspiracy and Role in Murder of Innocent Bystander in North Minneapolis - Department of Justice (.gov)